BACKGROUND AND PURPOSE: Evidence is mounting that spinal cord atrophy significantly correlates with disability in patients with multiple sclerosis (MS). The purpose of this work was to validate 3 different measures for the measurement of cervical cord atrophy on high-resolution MR imaging in patients with MS and in normal control subjects (NCs). We also wanted to evaluate the relationship between cervical cord atrophy and clinical disability in the presence of other conventional and nonconventional brain MR imaging metrics by using a unique additive variance regression model. MATERIALS AND METHODS: We studied 66 MS patients (age, 41.2 +/- 12.4 years; disease duration, 11.8 +/- 10.7 years; Expanded Disability Status Scale, 3.1 +/- 2.1) and 19 NCs (age, 30.4 +/- 12.0 years). Disease course was relapsing-remitting (34), secondary-progressive (14), primary-progressive (7), and clinically isolated syndrome (11). The cervical cord absolute volume (CCAV) in cubic millimeters and 2 normalized cervical cord measures were calculated as follows: cervical cord fraction (CCF) = CCAV/thecal sac absolute volume, and cervical cord to intracranial volume (ICV) fraction (CCAV/ICV). Cervical and brain lesion volume measures, brain parenchyma fraction (BPF), and mean diffusivity were also calculated. RESULTS: CCAV (P < .0001) and CCF (P = .007) showed the largest differences between NCs and MS patients and between different disease subtypes. In regression analysis predicting disability, CCAV was retained first (R(2) = 0.498; P < .0001) followed by BPF (R(2) = 0.08; P = .08). Only 8% of the variance in disability was explained by brain MR imaging measures when coadjusted for the amount of cervical cord atrophy. CONCLUSIONS: 3D CCAV measurement showed the largest differences between NCs and MS patients and between different disease subtypes. Cervical cord atrophy measurement provides valuable additional information related to disability that is not obtainable from brain MR imaging metrics.
BACKGROUND AND PURPOSE: Evidence is mounting that spinal cord atrophy significantly correlates with disability in patients with multiple sclerosis (MS). The purpose of this work was to validate 3 different measures for the measurement of cervical cord atrophy on high-resolution MR imaging in patients with MS and in normal control subjects (NCs). We also wanted to evaluate the relationship between cervical cord atrophy and clinical disability in the presence of other conventional and nonconventional brain MR imaging metrics by using a unique additive variance regression model. MATERIALS AND METHODS: We studied 66 MSpatients (age, 41.2 +/- 12.4 years; disease duration, 11.8 +/- 10.7 years; Expanded Disability Status Scale, 3.1 +/- 2.1) and 19 NCs (age, 30.4 +/- 12.0 years). Disease course was relapsing-remitting (34), secondary-progressive (14), primary-progressive (7), and clinically isolated syndrome (11). The cervical cord absolute volume (CCAV) in cubic millimeters and 2 normalized cervical cord measures were calculated as follows: cervical cord fraction (CCF) = CCAV/thecal sac absolute volume, and cervical cord to intracranial volume (ICV) fraction (CCAV/ICV). Cervical and brain lesion volume measures, brain parenchyma fraction (BPF), and mean diffusivity were also calculated. RESULTS: CCAV (P < .0001) and CCF (P = .007) showed the largest differences between NCs and MSpatients and between different disease subtypes. In regression analysis predicting disability, CCAV was retained first (R(2) = 0.498; P < .0001) followed by BPF (R(2) = 0.08; P = .08). Only 8% of the variance in disability was explained by brain MR imaging measures when coadjusted for the amount of cervical cord atrophy. CONCLUSIONS: 3D CCAV measurement showed the largest differences between NCs and MSpatients and between different disease subtypes. Cervical cord atrophy measurement provides valuable additional information related to disability that is not obtainable from brain MR imaging metrics.
Authors: M A Rocca; G Mastronardo; M A Horsfield; C Pereira; G Iannucci; B Colombo; L Moiola; G Comi; M Filippi Journal: AJNR Am J Neuroradiol Date: 1999-10 Impact factor: 3.825
Authors: G J Nijeholt; M A van Walderveen; J A Castelijns; J H van Waesberghe; C Polman; P Scheltens; P F Rosier; P J Jongen; F Barkhof Journal: Brain Date: 1998-04 Impact factor: 13.501
Authors: R Zivadinov; R A Rudick; R De Masi; D Nasuelli; M Ukmar; R S Pozzi-Mucelli; A Grop; G Cazzato; M Zorzon Journal: Neurology Date: 2001-10-09 Impact factor: 9.910
Authors: D Kidd; J W Thorpe; B E Kendall; G J Barker; D H Miller; W I McDonald; A J Thompson Journal: J Neurol Neurosurg Psychiatry Date: 1996-01 Impact factor: 10.154
Authors: Ralph H B Benedict; Jared M Bruce; Michael G Dwyer; Nadir Abdelrahman; Sarah Hussein; Bianca Weinstock-Guttman; Neeta Garg; Frederick Munschauer; Robert Zivadinov Journal: Arch Neurol Date: 2006-09
Authors: Christopher R Tench; Paul S Morgan; Timothy Jaspan; Dorothee P Auer; Cris S Constantinescu Journal: J Neuroimaging Date: 2005 Impact factor: 2.486
Authors: I Trop; P M Bourgouin; Y Lapierre; P Duquette; C M Wolfson; H D Duong; G C Trudel Journal: AJNR Am J Neuroradiol Date: 1998 Jun-Jul Impact factor: 3.825
Authors: W Rashid; G R Davies; D T Chard; C M Griffin; D R Altmann; R Gordon; A J Thompson; D H Miller Journal: J Neurol Neurosurg Psychiatry Date: 2006-01 Impact factor: 10.154
Authors: Lindsay S Cahill; Monan Angela Zhang; Valeria Ramaglia; Heather Whetstone; Melika Pahlevan Sabbagh; Tae Joon Yi; Laura Woo; Thomas S Przybycien; Marina Moshkova; Fei Linda Zhao; Olga L Rojas; Josephine Gomes; Stefanie Kuerten; Jennifer L Gommerman; John G Sled; Shannon E Dunn Journal: Proc Natl Acad Sci U S A Date: 2019-10-22 Impact factor: 11.205
Authors: Adam B Cohen; Mohit Neema; Ashish Arora; Elisa Dell'oglio; Ralph H B Benedict; Shahamat Tauhid; Daniel Goldberg-Zimring; Christian Chavarro-Nieto; Antonella Ceccarelli; Joshua P Klein; James M Stankiewicz; Maria K Houtchens; Guy J Buckle; David C Alsop; Charles R G Guttmann; Rohit Bakshi Journal: J Neuroimaging Date: 2011-03-29 Impact factor: 2.486
Authors: Nico Papinutto; Carlo Asteggiano; Antje Bischof; Tristan J Gundel; Eduardo Caverzasi; William A Stern; Stefano Bastianello; Stephen L Hauser; Roland G Henry Journal: J Neuroimaging Date: 2019-09-30 Impact factor: 2.486
Authors: F X Aymerich; C Auger; J Alonso; M Alberich; J Sastre-Garriga; M Tintoré; X Montalban; A Rovira Journal: AJNR Am J Neuroradiol Date: 2017-12-28 Impact factor: 3.825
Authors: Kathleen M Zackowski; Seth A Smith; Daniel S Reich; Eliza Gordon-Lipkin; BettyAnn A Chodkowski; Divya R Sambandan; Michael Shteyman; Amy J Bastian; Peter C van Zijl; Peter A Calabresi Journal: Brain Date: 2009-03-18 Impact factor: 13.501